[
drugs controller general of india
]Latest from drugs controller general of india
DCGI asks doctors to advise patients against use of Pholcodine cough syrups
The DCGI has issued an alert on cough and cold remedies containing Pholcodine due to safety concerns triggering severe allergic reactions.
Published on Jul 20, 2023 01:21 PM IST
Test cough syrups meant for exports on priority: DCGI
DCGI on Wednesday directed state drugs regulators and government laboratories to test cough syrup samples meant for exports “on top priority” and issue reports at the earliest.
Updated on May 25, 2023 12:34 AM IST
Rhythma Kaul, New Delhi
Covovax to be available on CoWIN as booster dose soon. Check details
Covovax is likely to be available on the portal in a few days at a price of ₹225 per dose plus applicable GST.
Published on Apr 10, 2023 05:00 PM IST
PTI |
Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults
Last month, COVID-19 Working Group also recommended to the health ministry inclusion of Covovax on the CoWIN portal as a heterologous booster dose for adults.
Published on Apr 03, 2023 08:10 PM IST
PTI |
Gambia deaths: Expert dismisses fears about Indian cough syrups
Gambia alleged that kidney injuries linked to India-made paracetamol syrup caused 66 child deaths in the past three months.
Published on Oct 08, 2022 02:03 PM IST
Nisha Anand | Edited by Poulomi Ghosh
